CSIMarket
Quotient Limited  (QTNT)
Other Ticker:  
 
 

Quotient Limited's Yearly Capital Expenditures Growth 5 Years

 

Select the Comparisons : Select the Ratio:



QTNT Annual Capital Expenditures Growth

2022
2021
2020
2019
2018
Y / Y Annual Capital Expenditures Change -32.76 % -7.83 % -4.05 % -77.96 % -
Annual Capital Expenditures (in millions $) $2.85 $4.24 $4.60 $4.79 $21.75


Annual Capital Expenditures Growth Comment
Quotient Limited experienced detoriation of Annual Capital Expenditures for the fiscal year ended 2022 by -32.76% to $ 2.85 millions, compare to $ 4.24 in Annual Capital Expenditures reported in the previous year. The decline in company's annual Capital Expenditures accelerated, from the -7.83 % decrease, in the fiscal year ended 2021.

Quotient Limited Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2022 Annual Capital Expenditures within Healthcare SectorY/Y Capital Expenditures Growth %2022 Annual Capital Expenditures
Sinovac Biotech Ltd -98.67 %$ 9.568  millions
Blueprint Medicines Corporation -96.59 %$ 8.919  millions
Lyell Immunopharma Inc -62.94 %$ 24.276  millions
Exelixis Inc -56.86 %$ 27.706  millions
Adaptive Biotechnologies Corporation -73.52 %$ 16.349  millions
Cytokinetics Incorporated -76.81 %$ 11.335  millions
Bridgebio Pharma Inc -86.90 %$ 6.321  millions
Absci Corp -57.49 %$ 16.175  millions
Iovance Biotherapeutics Inc -45.64 %$ 20.425  millions
Orasure Technologies Inc -81.50 %$ 6.774  millions
Atreca inc -97.48 %$ 0.885  millions
Allakos Inc -74.92 %$ 8.333  millions
Lhc Group Inc -40.53 %$ 19.610  millions
Burning Rock Biotech Limited -72.21 %$ 9.021  millions
Opko Health Inc -23.57 %$ 24.578  millions
Signify Health Inc -1.05 %$ 28.300  millions
Amphastar Pharmaceuticals Inc -12.46 %$ 24.034  millions
Neogen Corporation -8.55 %$ 24.429  millions
Ascendis Pharma A -38.88 %$ 16.228  millions
Arcus Biosciences Inc -76.99 %$ 6.000  millions
Passage Bio inc -79.43 %$ 5.274  millions
Livanova Plc  4.08 %$ 26.517  millions
Novocure Limited -11.63 %$ 21.358  millions
Fulgent Genetics Inc -21.26 %$ 18.775  millions

Other Companies within Healthcare Sector and their 2022 Capital Expenditures

Y/Y Annual Capital Expenditures Growth %

2022 Capital Expenditures
Chemed Corporation -2.30 %$ 57.325  millions
Abcellera Biologics Inc   24.31 %$ 72.660  millions
Instil Bio Inc   46.27 %$ 84.589  millions
Surgery Partners Inc   39.93 %$ 80.600  millions
Novavax inc  61.75 %$ 92.985  millions
Globus Medical Inc   30.14 %$ 74.047  millions
Syneos Health Inc   64.42 %$ 93.459  millions
Invitae Corporation -2.58 %$ 53.309  millions
Envista Holdings Corporation  38.39 %$ 75.700  millions
Integer Holdings Corporation  39.78 %$ 74.728  millions
Abiomed Inc -33.01 %$ 35.763  millions
Seagen Inc   47.79 %$ 77.340  millions
Fate Therapeutics Inc -29.86 %$ 35.566  millions
Owens and Minor inc  235.24 %$ 166.582  millions
Amneal Pharmaceuticals Inc   78.46 %$ 88.207  millions
Warby Parker Inc   24.05 %$ 60.181  millions
Integra Lifesciences Holdings Corp -11.83 %$ 42.343  millions
Glaukos Corp -36.66 %$ 30.265  millions
Concord Medical Services Holdings Ltd -30.77 %$ 32.448  millions





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com